title: Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications.
abstract: The prevalence of microalbuminuria and its relationship with several cardiovascular risk factors and target organ damage were evaluated in a cohort of 787 untreated patients with essential hypertension. Albuminuria was measured as the albumin-to-creatinine ratio in three nonconsecutive, first morning urine samples. The prevalence of microalbuminuria was 6.7%. Albuminuric patients were more likely to be men and to be characterized by higher blood pressure, body mass index, and uric acid levels and lower HDL cholesterol and HDL cholesterol-to-LDL cholesterol ratio. Piecewise linear regression analysis demonstrated that uric acid and diastolic blood pressure significantly influence albuminuria and together account for a large part of its variations. K-means cluster analysis performed on the entire cohort of patients confirmed that microalbuminuria is associated with a worse cardiovascular risk profile. Furthermore, microalbuminuria was associated with the presence of target organ damage (eg, electrocardiographic [ECG] abnormalities and retinal vascular changes). Age and the presence of microalbuminuria act as independent risk factors for the development of ECG abnormalities and retinal vascular changes. Cluster analysis allowed us to identify three subgroups of patients who differed in the presence or absence of microalbuminuria, retinopathy, and ECG abnormalities. We conclude that the prevalence of microalbuminuria in essential hypertension is lower than previously reported. Increased urinary albumin excretion is associated with a worse cardiovascular risk profile and is a concomitant indicator of early target organ damage.
authors.affiliation: Department of Internal Medicine, University of Genoa, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Pontremoli
authors.forename: A
authors.initials: A
authors.lastname: Sofia
authors.forename: M
authors.initials: M
authors.lastname: Ravera
authors.forename: C
authors.initials: C
authors.lastname: Nicolella
authors.forename: F
authors.initials: F
authors.lastname: Viazzi
authors.forename: A
authors.initials: A
authors.lastname: Tirotta
authors.forename: N
authors.initials: N
authors.lastname: Ruello
authors.forename: C
authors.initials: C
authors.lastname: Tomolillo
authors.forename: C
authors.initials: C
authors.lastname: Castello
authors.forename: G
authors.initials: G
authors.lastname: Grillo
authors.forename: G
authors.initials: G
authors.lastname: Sacchi
authors.forename: G
authors.initials: G
authors.lastname: Deferrari
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000453:epidemiology* / Q000209:etiology / Q000503:physiopathology*; D016000:Cluster Analysis; D003404:Creatinine / Q000097:blood / Q000652:urine; D005260:Female; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000235:genetics / Q000503:physiopathology / Q000652:urine*; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D015995:Prevalence; D012164:Retinal Diseases / Q000209:etiology
chemical_list: D003404:Creatinine